autologous anti-FGFR4 CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-011428
A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen receptor (CAR) targeting human fibroblast growth factor receptor 4 (FGFR4), with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-FGFR4 CAR T cells recognize and induce selective toxicity in FGFR4-expressing tumor cells. FGFR4, a receptor tyrosine kinase, is involved in angiogenesis and in the proliferation, differentiation, and survival of tumor cells.
| Identifier | MLC-T-ONC-011428 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous anti-FGFR4 CAR-T cells; autologous FGFR4-CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011428",
"term": "autologous anti-FGFR4 CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen receptor (CAR) targeting human fibroblast growth factor receptor 4 (FGFR4), with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-FGFR4 CAR T cells recognize and induce selective toxicity in FGFR4-expressing tumor cells. FGFR4, a receptor tyrosine kinase, is involved in angiogenesis and in the proliferation, differentiation, and survival of tumor cells.",
"synonyms": [
"autologous anti-FGFR4 CAR-T cells",
"autologous FGFR4-CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-fgfr4-car-t-cells/"
}
Record 2,760 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.